קונבריזה

Država: Izrael

Jezik: hebrejščina

Source: Ministry of Health

Aktivna sestavina:

BAZEDOXIFENE AS ACETATE 20 MG

Dostopno od:

NEOPHARM LTD

Koda artikla:

G03XC02

Farmacevtska oblika:

COATED TABLETS

Pot uporabe:

PER OS

Izdeluje:

PFIZER IRELAND PHARMACEUTICALS

Terapevtska skupina:

BAZEDOXIFENE

Terapevtske indikacije:

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

Datum dovoljenje:

2013-04-01